NR6A1 and lung carcinoma: Through a series of experiments, including bioinformatics analysis, dual-luciferase reporter gene expression, RT‒qPCR and Western blot analysis, we proved that NR6A1 could inhibit miR-302a in lung cancer cells, thereby indirectly promoting the expression of HK1.